• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BBK Worldwide expands ownership from within

BBK Worldwide expands ownership from within

March 25, 2013
CenterWatch Staff

In an industry increasingly defined by mergers and acquisitions, BBK Worldwide is bucking the trend by creating ownership opportunities from within.

Celebrating 30 years, Newton, Mass.-based BBK remains one of the only independent and self-funded patient recruitment agencies. Now BBK has named four additional principals who, together, will assume a minority ownership in the company.

All long-serving employees, Matthew Kibby, Rob Laurens, Liz Ritchie and Matthew Stumm have played key roles in shaping the company's success. As principals, they will partner with BBK's founding principals Joan F. Bachenheimer and Bonnie A. Brescia to maintain the company's core mission and values while driving growth in key market areas.

"These four individuals have made unyielding contributions to BBK over the years—contributions that have brought innovation and definition to the patient recruitment marketplace as a whole," said Bachenheimer. "Their new roles will allow for expanded growth in critical business areas, ensuring that current and future customers benefit from the most strategic and sophisticated thinking in the industry."

 Each newly named principal will focus efforts on expanding his or her current management area. Matthew Stumm will drive innovation for Agency320, BBK's partner company for creative and media services. Rob Laurens will advance patient recruitment training and industry best practices. Liz Ritchie will continue to manage corporate and legal services. Matthew Kibby will expand and refine product offerings from BBK's technology partner TCN Technologies and its hallmark product TrialCentralNet.

Companies often turn to mergers and acquisitions as a corporate strategy for creating growth, however, often at the expense of innovation. BBK's move represents a deliberate shift from this industry trend.

"Over the past 10 years, BBK has been approached by several different organizations interested in taking an outside investment in BBK," said Brescia. "We've taken a different approach that values the commitment and dedication of our employees. Our business model reflects our commitment to, and appreciation for, our employees and for their hard work and investment. This dynamic model creates opportunities to expand ownership from within."

BBK created a new corporate structure that also has the potential to seamlessly expand ownership opportunities to other deserved employees within the company—ensuring retention of key talent and the viability of the company moving forward.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing